 corticosteroid adjunct therapi sever pneumocysti carinii pneumonia acquir immunodefici syndrom double-blind placebo-control trial background preliminari report patient acquir immunodefici syndrom aid pneumocysti pneumonia addit corticosteroid treatment antibiot therapi method double-blind placebo-control trial efficaci adjunct corticosteroid patient aid sever carinii pneumonia patient mark abnorm ga exchang antibiot hour methylprednisolon mg hour day addit treatment day trimethoprim-sulfamethoxazol primari outcom measur surviv hospit discharg develop respiratori failur result twenty-thre patient studi signific differ base-lin clinic laboratori measur treatment group patient corticosteroid percent hospit discharg placebo recipi percent respiratori failur placebo recipi patient corticosteroid patient interrupt discontinu corticosteroid antibiot treatment toxic complic event mark differ surviv uneth trial studi conclus earli adjunct corticosteroid therapi surviv occurr respiratori failur patient aid sever carinii pneumonia